Miho Kuroiwa

Reduced susceptibility mechanism to cefiderocol, a siderophore cephalosporin, among clinical isolates from a global surveillance programme (SIDERO-WT-2014)

Naoki Kohira, Meredith Hackel, Yoshino Ishioka et al. · Journal of Global Antimicrobial Resistance · 2020 · 102 citations · Full text

Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan

Yoshinori Yamano, Naoki Ishibashi, Miho Kuroiwa et al. · Journal of Global Antimicrobial Resistance · 2021 · 36 citations · Full text

696. Mechanism of Cefiderocol high MIC mutants obtained in non-clinical FoR studies

Akinobu Ito, Toru Nishikawa, Ryuta Ishii et al. · Open Forum Infectious Diseases · 2018 · 30 citations · Full text

Microbial Pathogens, Appeared Colonies, Molecular Biology +21

Contributions of <i>yap1</i> Mutation and Subsequent <i>atrF</i> Upregulation to Voriconazole Resistance in Aspergillus flavus

Yuuta Ukai, Miho Kuroiwa, Naoko Kurihara et al. · Antimicrobial Agents and Chemotherapy · 2018 · 24 citations · Full text

Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against <i>Stenotrophomonas maltophilia</i> between <i>in vitro</i> chemostat and <i>in vivo</i> murine infection models

Christian M Gill, Kamilia Abdelraouf, Merime Oota et al. · Journal of Antimicrobial Chemotherapy · 2021 · 17 citations